If cognitive-behavioral therapy is not effective for mild to moderate tic disorders, what is the next recommended step?

Prepare for the Burns Pediatric Test with our comprehensive quiz. Utilize flashcards and multiple choice questions, each with hints and explanations, to enhance your learning. Equip yourself for success!

Multiple Choice

If cognitive-behavioral therapy is not effective for mild to moderate tic disorders, what is the next recommended step?

Explanation:
When CBT trials don’t yield meaningful improvement in mild to moderate tic disorders, the next step is to bring in a pediatric behavioral specialist and consider medications. A pediatric behavioral specialist can reassess the diagnosis, optimize behavioral approaches (potentially adjusting or expanding to CBIT), and coordinate with a clinician on pharmacotherapy. Medications such as alpha-2 adrenergic agonists (like clonidine or guanfacine) or antipsychotics (such as risperidone) can reduce tic severity, chosen based on tic burden, comorbid conditions, and side-effect profiles. Other options listed—like hair cutting or long-term anti-streptococcal prophylaxis—aren’t standard treatments for typical tic disorders, so they aren’t appropriate next steps.

When CBT trials don’t yield meaningful improvement in mild to moderate tic disorders, the next step is to bring in a pediatric behavioral specialist and consider medications. A pediatric behavioral specialist can reassess the diagnosis, optimize behavioral approaches (potentially adjusting or expanding to CBIT), and coordinate with a clinician on pharmacotherapy. Medications such as alpha-2 adrenergic agonists (like clonidine or guanfacine) or antipsychotics (such as risperidone) can reduce tic severity, chosen based on tic burden, comorbid conditions, and side-effect profiles. Other options listed—like hair cutting or long-term anti-streptococcal prophylaxis—aren’t standard treatments for typical tic disorders, so they aren’t appropriate next steps.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy